HS
HighVista Strategies Portfolio holdings
AUM
$272M
1-Year Return
24.34%
This Quarter Return
+15.65%
1 Year Return
+24.34%
3 Year Return
+176.43%
5 Year Return
+271.23%
10 Year Return
+682.63%
AUM
$219M
AUM Growth
+$95.8M
(+78%)
Cap. Flow
+$84.3M
Cap. Flow
% of AUM
38.57%
Top 10 Holdings %
Top 10 Hldgs %
33.7%
Holding
163
New
55
Increased
48
Reduced
23
Closed
29
Top Buys
| 1 |
Invesco DB Commodity Index Tracking Fund
DBC
|
$31.6M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$3.49M |
| 3 |
AJRD
Aerojet Rocketdyne Holdings, Inc.
AJRD
|
$3.38M |
| 4 |
TXNM
TXNM Energy, Inc.
TXNM
|
$3.15M |
| 5 |
Indivior
INDV
|
$3.09M |
Top Sells
| 1 |
iShares Russell 1000 Value ETF
IWD
|
$4.25M |
| 2 |
Coupang
CPNG
|
$4.1M |
| 3 |
OSH
Oak Street Health, Inc.
OSH
|
$3.46M |
| 4 |
TEGNA Inc
TGNA
|
$2.44M |
| 5 |
First Horizon
FHN
|
$2.41M |
Sector Composition
| 1 | Healthcare | 46.57% |
| 2 | Technology | 13.44% |
| 3 | Communication Services | 5.29% |
| 4 | Consumer Discretionary | 4.52% |
| 5 | Financials | 3.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
KE Holdings
BEKE
$21.9B
| $392K | 0.18% |
26,407
+15,127
| +134% | +$225K |
|
127
Travere Therapeutics
TVTX
$1.89B
| $390K | 0.18% |
25,397
-96,437
| -79% | -$1.48M |
|
128
United Therapeutics
UTHR
$17.2B
| $385K | 0.18% |
1,742
-1,462
| -46% | -$323K |
|
129
Ascendis Pharma
ASND
$12B
| $373K | 0.17% |
4,175
-3,163
| -43% | -$282K |
|
130
Natera
NTRA
$22.9B
| $353K | 0.16% |
+7,255
| New | +$353K |
|
131
Ultragenyx Pharmaceutical
RARE
$3.01B
| $338K | 0.15% |
+7,326
| New | +$338K |
|
|
SWTX
132
DELISTED
SpringWorks Therapeutics
SWTX
| $306K | 0.14% |
11,688
-5,959
| -34% | -$156K |
|
133
Krystal Biotech
KRYS
$4.33B
| $297K | 0.14% |
2,530
-8,528
| -77% | -$1M |
|
134
Amylyx Pharmaceuticals
AMLX
$887M
| $297K | 0.14% |
+13,748
| New | +$297K |
|
|
135
TEGNA Inc
TGNA
$3.41B
| – | – |
-144,000
| Closed | -$2.44M |
|
136
T-Mobile US
TMUS
$284B
| – | – |
-2,310
| Closed | -$335K |
|
137
TransUnion
TRU
$17.3B
| – | – |
-3,980
| Closed | -$247K |
|
138
Take-Two Interactive
TTWO
$44.4B
| – | – |
-1,730
| Closed | -$206K |
|
139
Uber
UBER
$192B
| – | – |
-7,530
| Closed | -$239K |
|
140
Ventyx Biosciences
VTYX
$185M
| – | – |
-23,583
| Closed | -$790K |
|
141
Workday
WDAY
$61.7B
| – | – |
-1,760
| Closed | -$364K |
|
|
X
142
DELISTED
US Steel
X
| – | – |
-8,280
| Closed | -$216K |
|
|
EDR
143
DELISTED
Endeavor Group Holdings, Inc.
EDR
| – | – |
-19,160
| Closed | -$458K |
|
|
BLU
144
DELISTED
BELLUS Health Inc.
BLU
| – | – |
-68,292
| Closed | -$492K |
|
|
OSH
145
DELISTED
Oak Street Health, Inc.
OSH
| – | – |
-89,400
| Closed | -$3.46M |
|
|
RXDX
146
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| – | – |
-20,955
| Closed | -$2.25M |
|
147
Agilent Technologies
A
$36.4B
| – | – |
-1,890
| Closed | -$261K |
|
148
Akero Therapeutics
AKRO
$3.52B
| – | – |
-18,629
| Closed | -$713K |
|
|
AMRN
149
Amarin Corp
AMRN
$311M
| – | – |
-25,034
| Closed | -$751K |
|
150
Arvinas
ARVN
$559M
| – | – |
-19,197
| Closed | -$524K |
|